Mechanisms of diabetic neuropathy: Schwann cells

Handbook of Clinical Neurology

Volumn 126, Issue , 2014, Pages 401-428

  Mizisin, Andrew P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetic nerve injury; Endoneurial microenvironment; Myelinated and unmyelinated fibers; Pathogenic mechanisms; Schwann cell

Indexed keywords

ANIMAL; DIABETES MELLITUS; DIABETIC NEUROPATHIES; HUMAN; MYELIN SHEATH; NERVE FIBER; PATHOLOGY; PHYSIOLOGY; SCHWANN CELL;

ANIMALS; DIABETES MELLITUS; DIABETIC NEUROPATHIES; HUMANS; MYELIN SHEATH; NERVE FIBERS; SCHWANN CELLS;

EID: 84921973174     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53480-4.00029-1     Document Type: Chapter

References (292)

1. Aguayo A.J., Attiwell M., Trecarten J., et al. Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature 1977, 265:73-75.
2. Akude E., Zherebitskaya E., Chowdhury S.K.R., et al. 4-hydroxy-2-nonenal impairs mitochondrial physiology and induces aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res 2010, 17:28-38.
3. Arroyo E.J., Scherer S.S. On the molecular architecture of myelinated fibers. Histochem Cell Biol 2000, 113:1-18.
4. Balice-Gordon R.J., Bone L.J., Scherer S.S. Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 1998, 142:1095-1104.
5. Ballin R.H.M., Thomas P.K. Hypertrophic changes in diabetic neuropathy. Acta Neuropathol 1968, 11:93-102.
6. Beggs J., Johnson P.C., Olafsen A., et al. Innervation of the vasa nervorum: changes in human diabetics. J Neuropathol Exp Neurol 1992, 51:612-629.
7. Behse F., Buchthal F., Carlsen F., et al. Unmyelinated fibers and Schwann cells of sural nerve in neuropathy. Brain 1975, 98:493-510.
8. Behse F., Buchthal F., Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977, 40:1072-1082.
9. Beiswenger K.K., Calcutt N.A., Mizisin A.P. Dissociation of thermal hypoalgesia and epidermal innervation in streptozotocin-diabetic mice. Neurosci Lett 2008, 442:267-272.
10. Bestetti G., Rossi G.L., Zemp C. Changes in peripheral nerves of rats four months after induction of streptozotocin diabetes. A qualitative and quantitative study. Acta Neuropathol 1981, 54:129-134.
11. Bhat M.A. Molecular organization of axo-glial junctions. Curr Opin Neurobiol 2003, 13:552-559.
12. Bianchi R., Marelli C., Marini P., et al. Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study. Diabetologia 1990, 33:131-136.
13. Bianchi R., Buyukakilli B., Brines M., et al. Erythropoetin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A 2004, 101:823-828.
14. Bischoff A. Morphology of diabetic neuropathy. Horm Metab Res Suppl. 1980, 9:18-28.
15. Bolin L.M., Verity A.N., Silver J.E., et al. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995, 64:850-858.
16. Boucek P., Havrdova T., Voska L., et al. Severe depletion of intraepidermal nerve fibers in skin biopsies of pancreas transplant recipients. Transplant Proc 2005, 37:3574-3575.
17. Bradley J., Thomas P.K., King R.H.M., et al. Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy. Diabetologia 1990, 33:611-618.
18. Bradley J.L., Thomas P.K., King R.H.M., et al. A comparison of perineurial and vascular basal lamina changes in diabetic neuropathy. Acta Neuropathol 1994, 88:426-432.
19. Bradley J.L., King R.H.M., Muddle J.R., et al. The extracellular matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuropathol 2000, 99:539-546.
20. Bravenboer B., Kappelle A.C., Hamers F.P., et al. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 1992, 35:813-817.
21. Britland S.T., Young R.J., Sharma A.K., et al. Association of painful and painless diabetic neuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990, 39:898-908.
22. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992, 15:1835-1843.
23. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
24. Brownlee M. The pathobiology of diabetic complications. A unifying mechanism. Diabetes 2005, 54:1615-1625.
25. Brussee V., Cunningham F.A., Zochodne D.W. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004, 53:1824-1830.
26. Bunge R. Expanding roles for the Schwann cell: ensheathment, myelination, trophism, and regeneration. Curr Opin Neurobiol 1993, 3:805-809.
27. Bunge M.B. Regulation of extracellular matrix biosynthesis and assembly. Peripheral Neuropathy 1993, 299-316. Saunders, Philadelphia. 3rd edn. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
28. Calcutt N.A., Muir D., Powell H.C., et al. Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res 1992, 575:320-524.
29. Calcutt N.A., Campana W.M., Eskeland N.L., et al. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders peripheral nerve in diabetic rats. J Neuropathol Exp Neurol 1999, 58:628-636.
30. Calcutt N.A., Allendorfer K.L., Mizisin A.P., et al. Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Invest 2003, 111:507-514.
31. Calcutt N.A., Freshwater J.D., Mizisin A.P. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004, 47:718-724.
32. Calcutt N.A., Jolivalt C.G., Fernyhough P. Growth factors as therapeutics for diabetic neuropathy. Curr Drug Targets 2008, 9:47-59.
33. Cameron N.E., Cotter M.A. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997, 46(Suppl.):S31-S37.
34. Cameron N.E., Cotter M.A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 1999, 45:137-146.
35. Cameron N.E., Cotter M.A. Effects of extracellular metal chelator on neurovascular function in diabetic rats. Diabetologia 2001, 44:621-628.
36. +-ATPase activity and vascular supply in STZ-diabetic rats. Diabetes 1991, 40:1652-1658.
37. Cameron N.E., Cotter M.A., Robertson S., et al. Muscle and nerve dysfunction in rats with experimental galactosaemia. Exp Physiol 1992, 77:89-108.
38. Cameron N.E., Cotter M.A., Maxfield E.K. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 1993, 36:299-304.
39. Cameron N.E., Cotter M.A., Archibald V., et al. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 1994, 37:449-459.
40. Cameron N.E., Cotter M.A., Hohman T.C. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 1996, 39:172-182.
41. Cameron N.E., Cotter M.A., Horrobin D.H., et al. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 1998, 41:390-399.
42. Carlsen F., Behse F. Three dimensional analysis of Schwann cells associated with unmyelinated nerve fibers in human sural nerve. J Anat 1980, 130:545-557.
43. Catterall W.A., Goldin A.L., Waxman S.G. International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005, 57:397-409.
44. Chakrabarti S., Sima A.A.F., Nakajima T., et al. Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 1987, 30:244-251.
45. Cherian P.V., Kamijo M., Angelides K.J., et al. Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition. J Diabetes Complications 1996, 10:192-200.
46. Chopra J.S., Hurwitz L.J., Montgomery D.A.D. The pathogenesis of sural nerve changes in diabetes mellitus. Brain 1969, 92:391-418.
47. Collins G.H., Webster H.D.e.F., Victor M. The ultrastructure of myelin and axonal alterations in sciatic nerves of thiamine deficient and chronically starved rats. Acta Neuropathol 1964, 3:511-521.
48. Conti A.M., Malosio M.L., Scarpini E., et al. Myelin protein transcripts increase in experimental diabetes. Neurosci Lett 1993, 161:203-206.
49. Conti A.M., Scarpini E., Malosio M.L., et al. In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy. Neurosci Lett 1996, 207:65-69.
50. Cotter M.A., Cameron N.E., Keegan A., et al. Effects of acetyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes. Metabolism 1995, 44:1209-1214.
51. Cullum N.A., Mahon J., Stringer K., et al. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia 1991, 34:387-389.
52. Cunha J.M., Jolivalt C.G., Ramos K.M., et al. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism 2008, 57:873-881.
53. Curtis R., Adryan K.M., Zhu Y., et al. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nature 1993, 16:253-255.
54. Curtis R., Scherer S.S., Somogyi R., et al. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve. Neuron 1994, 12:191-204.
55. De Grandis D., Minardi C. Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomized, double-blind, placebo-controlled study. Drugs R D 2002, 3:223-231.
56. de Waegh S.M., Brady S.T. Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts. J Neurosci Res 1991, 30:201-212.
57. de Waegh S.M., Lee V.M.-Y., Brady S.T. Local modulation of neurofilaments phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992, 68:451-463.
58. + channel. J Neurosci 2004, 24:1236-1244.
59. Dowsing B., Morrison W.A., Nicola N.A., et al. Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem 1999, 73:96-104.
60. Drel V.R., Mashtalir N., Ilnytska O., et al. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 2006, 55:3335-3343.
61. Dyck P.J., Sherman W.R., Halicher L.M., et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980, 8:590-596.
62. Dyck P.J., Hansen S., Karnes J., et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci U S A 1985, 82:2513-2517.
63. Eames R.A., Gamble H.J. Schwann cell relationships in normal human cutaneous nerves. J Anat 1970, 106:417-438.
64. Eaton R.P., Qualls C., Sibbitt W.L., et al. Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis. Diabetologia 1996, 39:439-446.
65. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 2002, 50:293-321.
66. Engelstad J.K., Davies J.L., Giannini C., et al. No evidence for axonal atrophy in human diabetic polyneuropathy. J Neuropathol Exp Neurol 1997, 56:255-262.
67. Eshed Y., Feinberg K., Carey D.J., et al. Secreted gliomedin is a perinodal matrix component of peripheral nerves. J Cell Biol 2007, 177:551-562.
68. Estrella J.S., Nelson R.N., Sturges B.K., et al. Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc Res 2008, 75:403-410.
69. Fagerberg S.E. Diabetic neuropathy. A clinical and histological study on the significance of vascular affections. Acta Med Scand Suppl 1959, 86:345.
70. Fannon A.M., Sherman D.L., Ilyina-Gragerova G., et al. Novel E-cadherin mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 1995, 129:189-202.
71. Fawcett J.W., Keynes R.J. Peripheral nerve regeneration. Annu Rev Neurosci 1990, 13:43-60.
72. + channels during the formation of nodes of Ranvier. Neuron 2010, 65:490-502.
73. Feltri M.L., Suter U., Relvas J.B. The function of RhoGTPases in axon ensheathment and myelination. Glia 2008, 56:1508-1517.
74. Fernyhough P., Diemel L.T., Brewster W.J., et al. Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 1995, 64:1231-1237.
75. Fernyhough P., Diemel L.T., Tomlinson D.R. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 1998, 41:300-306.
76. Fernyhough P., Huang T.J., Verkhratsky A. Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J Peripher Nerv Syst 2003, 8:227-235.
77. Forcier N.J., Mizisin A.P., Rimmer M.A., et al. Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol Exp Neurol 1991, 50:235-255.
78. Funakoshi H., Frisen J., Barbany G., et al. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993, 123:455-465.
79. Gabbay K.H., O'Sullivan J.B. The sorbitol pathway - enzyme localization and content in normal and diabetic nerve and cord. Diabetes 1968, 17:239-243.
80. Gabbay K.H., Snider J.J. Nerve conduction defect in galactose-fed rats. Diabetes 1972, 21:295-300.
81. Gabbay K.H., Merola L.O., Field R.A. Sorbitol pathway: presence on nerve and cord with substrate accumulation in diabetes. Science 1966, 151:209-210.
82. Gao W.Q., Shinsky N., Ingle G., et al. IGF-1 deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-1 treatment. J Neurobiol 1999, 39:142-152.
83. Gartner J., Fischer F. Experimental autonomic neuropathy in the choroids of streptozotocin-diabetic rats. Electron microscopic observations. Retina 1989, 9:49-58.
84. Gatzinsky K.P., Persson G.H., Berthold C.H. Removal of retrogradely transported material from rat lumbosacral alpha-motor neurons by paranodal axon-Schwann cell networks. Glia 1997, 20:115-126.
85. -) mutant mice. Glia 2003, 42:340-349.
86. Ghani M., Malik R.A., Walker D., et al. Perineurial abnormalities in the spontaneously diabetic dog. Acta Neuropathol 1999, 97:98-102.
87. Giannini C., Dyck P.J. Ultrastructural morphometric abnormalities of sural nerve microvessels in diabetes mellitus. Ann Neurol 1994, 36:408-415.
88. Gibran N.S., Jang Y.C., Isik F.F., et al. Diminished neuropeptide levels contribute to impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002, 108:122-128.
89. Gold B.G., Mobley W.C., Matheson S.F. Regulation of axonal caliber, neurofilament content and nuclear localization in mature sensory neurons by nerve growth factor. J Neurosci 1991, 11:943-955.
90. +-ATPase regulation involved in pathogenesis of diabetic neuropathy?. Diabetes 1988, 37:688-693.
91. Griffey R.H., Eaton R.P., Sibbitt R.R., et al. Diabetic neuropathy. Structural analysis of nerve hydration by magnetic resonance spectroscopy. JAMA 1988, 260:2872-2878.
92. Grinspan J.B., Marchionni M.A., Reeves M., et al. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 1996, 16:6107-6118.
93. Hellweg R., Hartung H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990, 26:258-267.
94. Hirai A., Yasuda H., Joko M., et al. Evaluation of diabetic neuropathy through quantitation of cutaneous nerves. J Neurol Sci 2000, 172:55-62.
95. Hohman T.C., Banas D., Basso M., et al. Increased oxidative stress in experimental diabetic neuropathy. Diabetologia 1997, 40(Suppl. 1):A549.
96. Hounsom L., Corder R., Patel J., et al. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia 2001, 44:424-428.
97. Huang T.J., Price S.A., Chilton L., et al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type I diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003, 52:2129-2136.
98. Ichimura T., Ellisman M.H. Three-dimensional fine structure of cytoskeletal-membrane interactions at nodes of Ranvier. J Neurocytol 1991, 20:667-681.
99. Ihara C., Shimatsu A., Mizuta H., et al. Decreased neurotrophin-3 expression in skeletal muscles of streptozotocin-induced diabetic rats. Neuropeptides 1996, 30:309-312.
100. Jacobs J.M., Cavanaugh J.B. Aggregations of filaments in Schwann cells of spinal roots of the normal rat. J Neurocytol 1972, 1:161-167.
101. Jakobsen J. Axonal dwindling in early experimental diabetes. I A study of cross sectioned nerves. Diabetologia 1976, 12:539-546.
102. Jakobsen J. Axonal dwindling in early experimental diabetes. II A study of isolated nerve fibres. Diabetologia 1976, 12:547-553.
103. Jakobsen J. Peripheral nerves in early experimental diabetes. Expansion of the endoneurial space as a cause of increased water content. Diabetologia 1978, 14:113-119.
104. Jessen K.R., Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 2005, 6:671-682.
105. Jiang Y., Calcutt N.A., Ramos K.M., et al. Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. J Peripher Nerv Syst 2006, 11:274-285.
106. Jirmanova I. Giant axonopathy in streptozotocin diabetes of rats. Acta Neuropathol 1993, 86:42-48.
107. Johnson P.C., Doll S.C. Dermal nerves in human diabetic subjects. Diabetes 1984, 33:244-250.
108. Johnson P.C., Brendel K., Meezan E. Human diabetic perineurial cell basement membrane thickening. Lab Invest 1981, 44:265-270.
109. Johnson P.C., Doll S.C., Cromey D.W. Pathogenesis of diabetic neuropathy. Ann Neurol 1986, 19:450-457.
110. Johnson E.M., Taniuchi M., DiStefano P.S. Expression and possible function of nerve growth factor receptors on Schwann cells. Trends Neurosci 1988, 7:299-304.
111. Kalichman M.W., Dines K.C., Bobik M., et al. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes. Brain Res 1998, 810:130-137.
112. Kalichman M.W., Powell H.C., Mizisin A.P. Reactive, degenerative and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol 1998, 95:47-56.
113. Kamijo M., Basso M., Cherian P.V., et al. Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy. Diabetes Res Clin Pract 1994, 25:117-129.
114. Kamiya H., Zhang W., Sima A.A. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Ann Neurol 2004, 56:827-835.
115. Kamiya H., Zhang W., Ekberg K., et al. C-peptide reverses nociceptive neuropathy in type 1 diabetes. Diabetes 2006, 55:3581-3588.
116. Kato N., Mizuno K., Matsubara A., et al. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbo amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats. J Diabetes Complications 1994, 8:27-32.
117. Kato N., Mizuno K., Makino M., et al. Effects of 15-month aldose reductase inhibition with fidarestat on experimental diabetic neuropathy in rats. Diabetes Res Clin Pract 2000, 50:77-85.
118. Kawashima R., Kojima H., Nakamura K., et al. Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocin-induced diabetic rats. Neurochem Res 2007, 32:1002-1010.
119. Kennedy J.M., Zochodne D.W. Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?. Diabetes 2005, 54:830-837.
120. Kennedy W.R., Wendelschafer-Crabb G., Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996, 47:1042-1048.
121. Kern T.S., Engerman R.L. Immunohistochemical distribution of aldose reductase. Histochem J 1982, 14:507-515.
122. King R.H.M., Llewelyn J.G., Thomas P.K., et al. Perineurial calcification. Neuropathol Appl Neurobiol 1988, 14:105-123.
123. King R.H.M., Llewelyn J.G., Thomas P.K., et al. Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy. Neuropathol Appl Neurobiol 1989, 15:339-355.
124. Kishi Y., Schmelzer J.D., Yao J.K., et al. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 1999, 48:2045-2051.
125. Kishi M., Tanabe J., Schmelzer J.D., et al. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002, 51:819-824.
126. Konishi T. Voltage-gated potassium currents in myelinating Schwann cells in the mouse. J Physiol 1990, 431:123-139.
127. Korthals J.K., Gieron M.A., Dyck P.J. Intima of epineurial arterioles is increased in diabetic neuropathy. Neurology 1988, 38:1582-1586.
128. Koskinen M., Hietaharju A., Kylaniemi M., et al. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol 2005, 252:789-794.
129. Labasque M., Faivre-Sarrailh C. GPI-anchored proteins at the node of Ranvier. FEBS Lett 2010, 584:1787-1792.
130. Lambourne J.E., Tomlinson D.R., Brown A.M., et al. Opposite effects of diabetes and galactosemia on adenosine triphosphatase activity in rat nervous tissue. Diabetologia 1987, 30:360-362.
131. Lamontagne A., Buchthal F. Electrophysiological studies in diabetes mellitus. J Neurol Neurosurg Psychiatry 1970, 33:442-450.
132. Lauria G., McArthur J.C., Hauer P.E., et al. Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J Neurol Neurosurg Psychiatry 1998, 65:762-766.
133. Lauria G., Lombardi R., Borgna M., et al. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 2005, 10:202-208.
134. Leonelli E., Bianchi R., Cavaletti G., et al. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodel analysis. Neuroscience 2007, 144:1293-1304.
135. Levy D.M., Karanth S.S., Springall D.R., et al. Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia 1989, 32:427-433.
136. Levy D.M., Terenghi G., Gu X.H., et al. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 1992, 35:889-897.
137. Lindberger M., Schroder H., Schultzberg M., et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. J Neurol Sci 1989, 93:289-296.
138. Lindholm D., Heuman R., Meyer M., et al. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987, 330:658-659.
139. Llewelyn J.G., Patel N.J., Thomas P.K., et al. Sodium, potassium adenosine triphosphatase activity in peripheral nerve tissue of galactosemic rats. Effects of aldose reductase inhibition. Diabetologia 1987, 30:971-972.
140. Llewelyn J.G., Gilbey S.G., Thomas P.K., et al. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. Brain 1991, 114:867-892.
141. Love A., Cotter M.A., Cameron N.E. Effects of sulphydryl donor N-acetyl-L-cytsteine on nerve conduction: perfusion, maturation and regeneration freeze-damage in diabetic rats. Eur J Clin Invest 1996, 26:698-706.
142. Love A., Cotter M.A., Cameron N.E. Nerve function and regeneration in diabetic and galactosemic rats: antioxidant and metal chelator effects. Eur J Pharmacol 1996, 31:433-439.
143. Low P.A., Nickander K.K. Oxygen free radicals in sciatic nerve in experimental diabetes. Diabetes 1991, 40:873-877.
144. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46(Suppl. 2):S38-S42.
145. Lowitt S., Malone J.I., Salem A.F., et al. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 1995, 44:677-680.
146. Ludvigson M.A., Sorenson R.L. Immunohistochemical localization of aldose reductase. I. Enzyme purification and antibody preparation - localization in peripheral nerve, artery and testis. Diabetes 1980, 29:438-449.
147. Lui J., Atamna H., Kuratsuune H., et al. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci 2002, 959:133-166.
148. Mackenzie M.L., Ghabriel M.N., Allt G. Nodes of Ranvier and Schmidt-Lanterman incisures: an in vivo lanthanum tracer study. J Neurocytol 1984, 13:1043-1055.
149. Malik R.A., Newrick P.G., Sharma A.K., et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989, 32:92-102.
150. Malik R.A., Veves A., Masson E.A., et al. Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 1992, 55:557-561.
151. Malik R.A., Tesfaye S., Thompson S.D., et al. Endoneurial localization of microvascular damage in human diabetic neuropathy. Diabetologia 1993, 36:454-459.
152. Malik R.A., Tesfaye S., Thompson S.D., et al. Transperineurial abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res 1994, 48:236-245.
153. Malik R.A., Tesfaye S., Newrick P.G., et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005, 48:578-585.
154. Mann M.D. The Nervous System and Behavior 1981, Harper and Row, Philadelphia.
155. Matsuoka I., Meyer M., Hofer M., et al. Differential regulation of nerve growth factor and brain-derived neurotrophic factor expression in the peripheral nervous system. Ann N Y Acad Sci 1991, 633:550-552.
156. Maxwell D.S., Kruger L., Pineda A. The trigeminal nerve root with special references to the central-peripheral transition zone: an electron microscopic study in the macaque. Anat Rec 1969, 164:113-126.
157. McCallum K.N., Sharma A.K., Blanchard D.S., et al. The effect of continuous subcutaneous insulin infusion therapy on morphological and biochemical abnormalities of peripheral nerves in experimental diabetes. J Neurol Sci 1986, 74:55-67.
158. Medori R., Autilio-Gambetti L., Monaco S., et al. Experimental diabetic neuropathy: impairment of slow axonal transport with changes in axon cross-sectional area. Proc Natl Acad Sci U S A 1985, 82:7716-7720.
159. Meier C., Parmantier E., Brennan A., et al. Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving IGF, NT-3, and PDGF-BB. J Neurosci 1999, 19:3847-3859.
160. Mendell J.R., Whitaker J.N. Immunocytochemical localization studies of myelin basic protein. J Cell Biol 1978, 76:502-511.
161. Meyer M., Matsuoka I., Wetmore C., et al. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF m RNA. J Cell Biol 1992, 119:45-54.
162. + buffering are localized in microvilli of Schwann cells. J Neurosci 1996, 16:2421-2429.
163. Mirsky R., Parmantier E., McMahon A.P., et al. Schwann cell-derived desert hedgehog signals nerve sheath formation. Ann N Y Acad Sci 1999, 14:196-202.
164. +)-ATPase activity in galactose intoxication. Metabolism 1991, 40:1207-1212.
165. Mizisin A.P., Powell H.C. Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 1993, 52:78-86.
166. Mizisin A.P., Powell H.C. Diabetic peripheral neuropathy. Textbook of Diabetic Neuropathy 2003, 83-87. Thieme, Stuttgart. F.A. Gries, N.E. Cameron, P.A. Low (Eds.).
167. Mizisin A.P., Myers R.R., Powell H.C. Endoneurial sodium accumulation in galacotsemic rat nerves. Muscle Nerve 1986, 9:440-444.
168. Mizisin A.P., Powell H.C., Myers R.R. Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor. J Neurol Sci 1986, 74:35-43.
169. Mizisin A.P., Myers R.R., Heckman H.M., et al. Dose-dependence of endoneurial fluid sodium and chloride accumulation in galactose intoxication. J Neurol Sci 1988, 86:113-124.
170. Mizisin A.P., Bache M., DiStefano P.S., et al. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. J Neuropathol Exp Neurol 1997, 56:1290-1301.
171. Mizisin A.P., Calcutt N.A., DiStefano P.S., et al. Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes 1997, 46:647-652.
172. Mizisin A.P., Kalichman M.W., Bache M., et al. NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats. J Neuropathol Exp Neurol 1998, 57:803-813.
173. Mizisin A.P., Shelton G.D., Wagner S., et al. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy. Acta Neuropathol 1998, 95:171-174.
174. Mizisin A.P., Calcutt N.A., Tomlinson D.R., et al. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher Nerv Syst 1999, 4:211-221.
175. Mizisin A.P., DiStefano P.S., Li X., et al. Decreased accumulation of endogenous brain-derived neurotrophic factor against constricting sciatic nerve ligatures in streptozotocin-diabetic and galactose-fed rats. Neurosci Lett 1999, 263:1-4.
176. Mizisin A.P., Steinhardt R.C., O'Brien J.S., et al. TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats. J Neuropathol Exp Neurol 2001, 60:953-960.
177. Mizisin A.P., Shelton G.D., Burgers M.L., et al. Neurological complications associated with spontaneously occurring feline diabetes mellitus. J Neuropathol Exp Neurol 2002, 61:872-884.
178. Mizisin A.P., Vu Y., Shuff M., et al. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes 2004, 53:1807-1812.
179. Mizisin A.P., Nelson R.W., Sturges B.K., et al. Comparable myelinated nerve pathology in feline and human diabetes mellitus. Acta Neuropathol 2007, 113:431-442.
180. Moore S.A., Peterson R.G., Felten D.L., et al. Ultrastructrual axonal pathology in experimentally diabetic and aging control rats. Brain Res Bull 1982, 8:317-323.
181. Murakawa Y., Zhang W., Pierson C.R., et al. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev 2002, 18:473-483.
182. Murinson B.B., Griffen J.W. C-fiber structure varies with location in peripheral nerve. J Neuropathol Exp Neurol 2004, 63:246-254.
183. Myers R.R., Powell H.C. Galactose neuropathy: impact of chronic endoneurial edema on nerve blood flow. Ann Neurol 1984, 16:587-594.
184. Myers R.R., Costello M.L., Powell H.C. Increased endoneurial fluid pressure in galactose neuropathy. Muscle Nerve 1979, 2:299-303.
185. Nagafuchi A., Tsukita S., Takeichi M. Transmembrane control of cadherin-mediated cell-cell adhesion. Semin Cell Biol 1993, 4:175-181.
186. Nagamatsu M., Nickander K.K., Schmelzer J.D., et al. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995, 18:1160-1167.
187. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
188. Oates P.J. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol 2002, 50:326-392.
189. Obrosova I.G. How does glucose generate oxidative stress in peripheral nerve?. Int Rev Neurobiol 2002, 50:3-35.
190. Obrosova I.G., Fathallah L., Stevens M.J. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetes. Exp Neurol 2001, 172:211-219.
191. Obrosova I.G., Xu W., Lyzogubov V.V., et al. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med 2008, 44:972-981.
192. Ohi T., Saita K., Furukawa S., et al. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor. Exp Neurol 1998, 151:215-220.
193. Ohnishi A., Harada M., Tateishi J., et al. Segmental demyelination and remyelination in lumbar spinal roots of patients dying with diabetes mellitus. Ann Neurol 1983, 13:541-548.
194. Pare M., Albrecht P.J., Noto C.J., et al. Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes. J Comp Neurol 2007, 501:543-567.
195. Parmantier E., Lynn B., Lawson D., et al. Schwann cell-derived desert hedgehog controls the development of peripheral nerve sheaths. Neuron 1999, 23:713-724.
196. Pittenger G.L., Ray M., Burcus N.I., et al. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004, 27:1974-1979.
197. Powell H.C., Myers R.R. Schwann cell changes in chronic galactose neuropathy. Muscle Nerve 1983, 6:218-227.
198. Powell H.C., Knox D., Lee S., et al. Alloxan diabetic neuropathy: electron microscopic studies. Neurology 1977, 27:60-66.
199. Powell H.C., Rosoff J., Myers R.R. Microangiopathy in human diabetic neuropathy. Acta Neuropathol 1985, 68:295-305.
200. +-dependent p-nitro-phenylphosphatase in rat peripheral nerve. Acta Neuropathol 1991, 81:529-539.
201. Privat A., Jacque C., Bourre J.M., et al. Absence of the major dense line in myelin of the mutant mouse 'shiverer. Neurosci Lett 1979, 12:107-112.
202. Properzi G., Francavilla S., Poccia G., et al. Early increase precedes a depletion of VIP and PGP9.5 in the skin of insulin-dependent diabetics - correlation between quantitative immunohistochemistry and clinical assessment of peripheral neuropathy. J Pathol 1993, 169:269-277.
203. Pu S.F., Zhuang H.X., Ishii D.N. Differential spatio-temporal expression of the insulin-like growth factor genes in regenerating sciatic nerve. Mol Brain Res 1995, 34:18-28.
204. Rende M., Muir D., Ruoslahti E., et al. Localization and characterization of ciliary neuronotrophic factor in peripheral nerve. Glia 1992, 5:25-32.
205. Robertson D.M., Sima A.A. Diabetic neuropathy in the mutant [C57BL/ks(db/db)]: a morphometric study. Diabetes 1980, 29:60-67.
206. Rodriguez-Pena A., Botana M., Gonzalez M., et al. Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats. Neurosci Lett 1995, 200:37-40.
207. Roglio I., Bianchi R., Giatti S., et al. Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci 2007, 64:1158-1168.
208. Rosen P., Naworth P.P., King G., et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001, 17:189-212.
209. Russell J.W., Sullivan K.A., Windebank A.J., et al. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999, 6:347-363.
210. Ryle C., Leow C.K., Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 1997, 20:577-584.
211. Said G., Slama G., Selva J. Progressive centripedal degeneration of axons in small fiber type diabetic polyneuropathy. A clinical and pathological study. Brain 1983, 106:791-807.
212. Sandri C., Van Buren J.M., Akert K. Membrane morphology of the vertebrate nervous system. Prog Brain Res 1982, 46:201-265.
213. Sasaki H., Schmelzer J.D., Zollman P.J., et al. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol 1997, 93:118-128.
214. Sawada N., Ishida H., Collins B.E., et al. Ganglioside GD1 alpha analogues as high-affinity ligands fro myelin-associated glycoprotein (MAG). Carbohydr Res 1999, 316:1-5.
215. Schmeichel A.M., Schmelzer J.D., Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003, 52:165-171.
216. Schmidt R.E., Dorsey D.A., Beaudet L.N., et al. Insulin-like growth factor 1 reverses experimental diabetic autonomic neuropathy. Am J Pathol 1999, 155:1651-1660.
217. Schmidt R.E., Dorsey D.A., Beaudet L.N., et al. Analysis of the Zucker diabetic fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-1 in diabetic autonomic neuropathy. Am J Pathol 2005, 163:21-28.
218. Shapiro L., Fannon A.M., Kwong P.D., et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995, 374:327-337.
219. Sharghi-Namini S., Turmaine M., Meier C., et al. The structural and functional integrity of peripheral nerves depends on the glial-derived signal desert hedgehog. J Neurosci 2006, 26:6364-6376.
220. Sharma A.K., Thomas P.K., Gabriel G., et al. Peripheral nerve abnormalities in the diabetic mutant mouse. Diabetes 1983, 32:1152-1161.
221. Shun C.T., Chang Y.C., Wu H.P., et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004, 127:1593-1605.
222. Sima A.A. Peripheral neuropathy in the spontaneously diabetic BB-Wistar-rat. An ultrastructural study. Acta Neuropathol 1980, 51:223-227.
223. Sima A.A.F., Kamiya H. Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?. Curr Drug Targets 2008, 9:37-46.
224. Sima A.A., Robertson D.M. Peripheral neuropathy in the mutant diabetic mouse [C57BL/Ks (db/db)]. Acta Neuropathol 1978, 41:85-89.
225. Sima A.A., Robertson D.M. Peripheral neuropathy in the diabetic mutant mouse. An ultrastructural study. Lab Invest 1979, 40:627-632.
226. Sima A.A., Bouchier M., Christensen H. Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy. Ann Neurol 1983, 13:264-272.
227. Sima A.A.F., Lattimer S.A., Yagihashi S., et al. Axo-glial dysjunction: a novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest 1986, 77:474-484.
228. Sima A.A.F., Nathaniel V., Bril V., et al. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 1988, 81:349-364.
229. Sima A.A.F., Nathaniel V., Prashar A., et al. Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 1991, 40:1090-1099.
230. Sima A.A.F., Prashar A., Nathaniel V., et al. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Diabet Med 1993, 10:115-121.
231. Sima A.A., Ristic H., Merry A., et al. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the biobreeding Worcester rat. J Clin Invest 1996, 97:1900-1907.
232. Singhal A., Cheng C., Sun H., et al. Near nerve local insulin prevents conduction slowing in experimental diabetes. Brain Res 1997, 763:209-214.
233. Smith A.G., Ramachandran P., Tripp S., et al. Epidermal nerve fiber innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2005, 57:1701-1704.
234. Spencer P.S., Schaumberg H.H. Pathobiology of neurotoxic axonal degeneration. Physiology and Pathobiology of Axons 1978, 265-282. Raven, New York. S.G. Waxman (Ed.).
235. Spencer P.S., Thomas P.K. Ultrastructural studies of the dying-back process II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons. J Neurocytol 1974, 3:763-783.
236. Sredy J., Flam B.R., Sawicki D.R. Adenosine triphosphatase activity in sciatic nerve tissue of streptozotocin-induced diabetic rats with and without high dietary sucrose: effects of aldose reductase inhibition. Proc Soc Exp Med 1991, 197:135-142.
237. Srinivasan S., Stevens M., Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000, 49:1932-1938.
238. Stevens M.J. Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Diabet Med 1995, 12:292-295.
239. Stevens M.J., Dananberg J., Feldman E.L., et al. The linked roles of nitric oxide, aldose reductase and (Na+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin-diabetic rat. J Clin Invest 1994, 94:853-859.
240. Stevens M.J., Obrosova I.G., Cao X., et al. Effect of DL-a-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy. Diabetes 2000, 49:1006-1016.
241. Stoll G., Griffin J.W., Li C.Y., et al. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989, 18:671-683.
242. Sugimoto K., Yagihashi S. Effects of aminoguanidine on structural alterations in microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc Res 1997, 53:105-112.
243. Sugimoto K., Nishizawa Y., Horiuchi S., et al. Localization in human diabetic peripheral nerve of N(epsilon)-carbxymethyl-lysine-protein adducts, an advanced glycation endproduct. Diabetologia 1997, 40:1380-1387.
244. Sugimoto K., Murakawa Y., Zhang W., et al. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes Metab Res Rev 2000, 16:354-363.
245. Sugimoto K., Yasujima M., Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 2008, 14:953-961.
246. Sugimura K., Dyck P.J. Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy. J Neurol Sci 1981, 53:501-509.
247. Suter U., Snipes G.J. Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 1995, 18:45-75.
248. Tamura E., Parry G.J. Severe radicular pathology in rats with longstanding diabetes. J Neurol Sci 1994, 127:29-35.
249. Taniuchi M., Clark H.B., Johnson E.M. Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci U S A 1986, 83:4094-4098.
250. Tesfaye S., Harris N., Jakubowski J.J., et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993, 36:1266-1274.
251. Thomas P.K., Lascelles R.G. Schwann-cell abnormalities in diabetic neuropathy. Lancet 1965, 62:1355-1357.
252. Thomas P.K., Lascelles R.G. The pathology of diabetic neuropathy. Q J Med 1966, 140:489-509.
253. Thomas P.K., King R.H., Sharma A.K. Changes with age in the peripheral nerves of the rat. An ultrastructural study. Acta Neuropathol 1980, 52:1-6.
254. Thomas P.K., Berthold C.-H., Ochoa J. Microscopic anatomy of the peripheral nervous system. Peripheral Neuropathy 1993, 28-91. Saunders, Philadelphia. 3rd edn. P.J. Dyck, P.K. Thomas, J.W. Griffen (Eds.).
255. Thomas P.K., Beamish N.G., Small J.R., et al. Paranodal structure in diabetic sensory polyneuropathy. Acta Neuropathol 1996, 92:614-620.
256. Thrainsdottir S., Malik R.A., Dahlin L.B., et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes 2003, 52:2615-2622.
257. Timperley W.R., Ward J.D., Preston F.E., et al. Clinical and histological studies in diabetic neuropathy. A reassessment of vascular factors in relation to intravascular coagulation. Diabetologia 1976, 12:237-243.
258. Tomlinson D.R., Willars G.B., Carrington A.L. Aldose reductase inhibitors and diabetic complications. Pharmac Ther 1992, 54:151-194.
259. Toth C., Brussee V., Zochodne W. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 2006, 49:1081-1088.
260. Trapp B.D., Quarles R.H. Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 1982, 92:877-882.
261. Trapp B.D., Itoyama Y., Sternberger N.H., et al. Immunocytochemical localization of P0 protein in the Golgi complex membranes and myelin of developing rat Schwann cells. J Cell Biol 1981, 90:1-6.
262. Trapp B.D., Quarles R.H., Suzuki K. Immunocytochemical studies of quaking mice support a role for the myelin-associated glycoprotein in forming and maintaining the periaxonal space and periaxonal collar of myelinating Schwann cells. J Cell Biol 1984, 99:594-606.
263. Uehara K., Sugimoto K., Wada R., et al. Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats. J Diabetes Complications 1997, 11:194-202.
264. Vareniuk I., Pavlov I.A., Lyzogubov V.V., et al. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol 2007, 205:425-436.
265. Veves A., Malik R.A., Lye R.H., et al. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med 1991, 8:917-921.
266. Vincent A.M., Russell J.W., Low P., et al. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004, 25:612-628.
267. Vlassara H., Brownlee M., Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983, 32:670-674.
268. Vlassara H., Brownlee M., Cerami A. Recognition and uptake of human diabetic peripheral nerve myelin by macrophages. Diabetes 1985, 34:553-557.
269. Wada R., Koyama M., Mizukami H., et al. Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for type 2 diabtes. Diabetes Metab Res Rev 1999, 15:332-337.
270. Waldbillig R.J., LeRoith D. Insulin receptors in the peripheral nervous system: a structural and functional analysis. Brain Res 1987, 409:215-220.
271. Walker D., Carrington A., Cannan S.A., et al. Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. J Anat 1999, 195:419-427.
272. Walker D., Siddique I., Anderson H., et al. Nerve pathology in the type 1 diabetic dog: effects of treatment with sulindac. J Peripher Nerv Syst 2001, 6:219-226.
273. Waxman S.G. Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 1980, 3:141-150.
274. Weiner J.A., Chun J. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc Natl Acad Sci U S A 1999, 96:5233-5238.
275. Williams E., Timperley W.R., Ward J.D., et al. Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980, 33:462-470.
276. Williams S.K., Howarth N.L., Devenny J.J., et al. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc Natl Acad Sci U S A 1982, 79:6546-6550.
277. Wong V., Arriaga R., Lindsay R.M. Effects of ciliary neuronotrophic factor (CNTF) on ventral spinal cord neurons in culture. Soc Neurosci Abstr 1990, 16:384.
278. Wood J.G., Engel E.L. Peripheral nerve glycoproteins and myelin fine structure during development of rat sciatic nerve. J Neurocytol 1976, 5:605-615.
279. Yagihashi S., Matsunaga M. Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 1979, 129:357-366.
280. Yagihashi S., Sima A.A. Diabetic autonomic neuropathy in BB rat. Ultrastructural and morphometric changes in parasympathetic nerves. Diabetes 1986, 35:733-743.
281. Yagihashi S., Mishimura M., Baba M. Morphometrical analysis of the peripheral nerve lesions in experimental diabetes rats. Tohoku J Exp Med 1979, 129:139-144.
282. Yagihashi S., Tonosaki A., Yamada K., et al. Peripheral neuropathy in selectively inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies. Tohoku J Exp Med 1982, 138:39-48.
283. Yagihashi S., Kamijo M., Ido Y., et al. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozotocin-induced diabetic rats. Diabetes 1990, 39:690-696.
284. Yagihashi S., Kamijo M., Baba M., et al. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 1992, 41:47-52.
285. Yagihashi S., Wada R., Kamijo M., et al. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 1993, 68:296-307.
286. Yagihashi S., Yamagishi S.I., Wada R.R., et al. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 2001, 124:2448-2458.
287. Yang L.J.S., Zeller C.B., Shaper N.L., et al. Gangliosides are neuronal ligands for myelin-associated glycoproteins. Proc Natl Acad Sci U S A 1996, 93:814-818.
288. Yasuda H., Dyck P.J. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987, 37:20-28.
289. Yasuda H., Sonobe M., Yamashita M., et al. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozotocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes 1989, 38:832-838.
290. Zhang W., Murakawa Y., Wozniak K.M., et al. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab Res Rev 2007, 23:63-70.
291. Zochodne D.W. Diabetic neuropathies: features and mechanisms. Brain Pathol 1999, 9:369-391.
292. Zochodne D.W., Sun H.S., Cheng C., et al. Accelerated diabetic neuropathy in axons without neurofilaments. Brain 2004, 127:2193-2200.